Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aggressive thyroid cancer: targeted therapy with sorafenib.
Corrado A, Ferrari SM, Politti U, Mazzi V, Miccoli M, Materazzi G, Antonelli A, Ulisse S, Fallahi P, Miccoli P. Corrado A, et al. Minerva Endocrinol. 2017 Mar;42(1):64-76. doi: 10.23736/S0391-1977.16.02229-X. Epub 2015 Jun 26. Minerva Endocrinol. 2017. PMID: 26112458 Review.
Sorafenib and thyroid cancer.
Fallahi P, Ferrari SM, Santini F, Corrado A, Materazzi G, Ulisse S, Miccoli P, Antonelli A. Fallahi P, et al. Among authors: corrado a. BioDrugs. 2013 Dec;27(6):615-28. doi: 10.1007/s40259-013-0049-y. BioDrugs. 2013. PMID: 23818056 Review.
CLM29, a multi-target pyrazolopyrimidine derivative, has anti-neoplastic activity in medullary thyroid cancer in vitro and in vivo.
Antonelli A, Bocci G, La Motta C, Ferrari SM, Fallahi P, Corrado A, Fioravanti A, Sartini S, Orlandi P, Piaggi S, Corti A, Materazzi G, Galleri D, Ulisse S, Fontanini G, Danesi R, Da Settimo F, Miccoli P. Antonelli A, et al. Among authors: corrado a. Mol Cell Endocrinol. 2014 Aug 5;393(1-2):56-64. doi: 10.1016/j.mce.2014.06.002. Epub 2014 Jun 12. Mol Cell Endocrinol. 2014. PMID: 24931161
Thyroid dysfunctions induced by tyrosine kinase inhibitors.
Fallahi P, Ferrari SM, Vita R, Di Domenicantonio A, Corrado A, Benvenga S, Antonelli A. Fallahi P, et al. Among authors: corrado a. Expert Opin Drug Saf. 2014 Jun;13(6):723-33. doi: 10.1517/14740338.2014.913021. Epub 2014 May 12. Expert Opin Drug Saf. 2014. PMID: 24821006 Review.
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity.
Fallahi P, Ferrari SM, Corrado A, Giuggioli D, Ferri C, Antonelli A. Fallahi P, et al. Among authors: corrado a. Recent Pat Endocr Metab Immune Drug Discov. 2014;8(2):95-101. doi: 10.2174/1872214808666140623114315. Recent Pat Endocr Metab Immune Drug Discov. 2014. PMID: 24953644 Review.
Autoimmune thyroid disorders.
Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P. Antonelli A, et al. Among authors: corrado a. Autoimmun Rev. 2015 Feb;14(2):174-80. doi: 10.1016/j.autrev.2014.10.016. Epub 2014 Oct 25. Autoimmun Rev. 2015. PMID: 25461470 Review.
Mixed cryoglobulinemia and thyroid autoimmune disorders.
Fallahi P, Ferrari SM, Giuggioli D, Corrado A, Fabiani S, Marchi S, Ferri C, Antonelli A. Fallahi P, et al. Among authors: corrado a. Clin Ter. 2013;164(4):e337-41. doi: 10.7417/CT.2013.1598. Clin Ter. 2013. PMID: 24045533
400 results